The gut microbiota of HCC patients who underwent triple therapy with local therapy combined with lenvatinib and PD-1 inhibitors exhibited structural similarities to those of patients with primary untreated HCC at the phylum level. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.